Evaluation of the in vitro and in vivo biocompatibility of carrageenanbased hydrogels

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 11, 2014, Pages 4087-4097

  Popa, Elena G ^a   Carvalho, Pedro P ^a   Dias, Ana F ^a   Santos, Tircia C ^a   Santo, Vitor E ^a   Marques, Alexandra P ^a   Viegas, Carlos A ^a,b   Dias, Isabel R ^a,b   Gomes, Manuela E ^a   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Adipose derived stem cells; Cartilage tissue engineering; Chondrogenic differentiation; Hydrogels; carrageenan

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELL ENGINEERING; DIAGNOSIS; MEDICAL APPLICATIONS; OXYGEN; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ADIPOSE DERIVED STEM CELLS; BIOMEDICAL APPLICATIONS; CARRAGEENANS; CARTILAGE TISSUE ENGINEERING; CHONDROGENIC DIFFERENTIATION; POLYMORPHONUCLEAR NEUTROPHILS; REACTIVE OXYGEN SPECIES; TISSUE ENGINEERING APPLICATIONS;

HYDROGELS;

CARRAGEENAN; HYDROXYL RADICAL; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL METABOLISM; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; EXPLANT; FIBROBLAST CULTURE; GELATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYDROGEL; IMMUNITY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; L929 CELL LINE; MALE; NEUTROPHIL; NONHUMAN; RAT; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CHEMICALLY INDUCED; CHEMISTRY; MATERIALS TESTING; METABOLISM; MONONUCLEAR CELL; MOUSE; PHARMACOLOGY; WISTAR RAT;

ANIMALS; CARRAGEENAN; CELL LINE; HUMANS; HYDROGELS; HYDROXYL RADICAL; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MATERIALS TESTING; MICE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 84908067146     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35081     Document Type: Article

References (56)

1. Williams DJ, Sebastine IM. Tissue engineering and regenerative medicine: manufacturing challenges. IEE Proceedings - Nanobiotechnology, 2005;152:207-210.
2. Corona BT, Ward CL, Harrison BS, Christ GJ. Regenerative Medicine: Basic Concepts, Current Status, and Future Applications. J Investig Med 2010;58:849-858.
3. Berthiaume FO, Maguire TJ, Yarmush ML. Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges. Ann Rev Chem Biomol Eng 2011;2:403-430.
4. Prasad KDVY, Margam C, John Yong Ming S. Recent advances and current developments in tissue scaffolding. Bio-Med Mater Eng 2005;15:159-177.
5. Chai C, Leong KW. Biomaterials Approach to Expand and Direct Differentiation of Stem Cells. Mol Ther 2007;15:467-480.
6. Smith GDW. The Williams dictionary of biomaterials. Mater Today 1999;2:29-000.
7. David WF. On the mechanisms of biocompatibility. Biomaterials 2008;29:2941-2953.
8. Grieshaber SE, Jha AK, Farran AJE, Jia X. Hydrogels in Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends, 1st ed. NewYork: Springer, 2011. p 9-46.
9. Tan H, Marra KG. Biodegradable Hydrogels for Tissue Engineering Applications. Materials 2010;3:1746-1767.
10. Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, Boesel LF, Oliveira JM, Santos TC, Marques AP, Neves NM, Reis RL. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J Roy Soc Interface 2007;4:999-1030.
11. Morais J, Papadimitrakopoulos F, Burgess D. Biomaterials/Tissue Interactions: Possible Solutions to Overcome Foreign Body Response. AAPS J 2010;12:188-196.
12. Yannas IV, Material science and engineering. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: An Introduction to Materials in Medicine, 2nd ed. London: Elsevier Academic Press; 2004. p 84-97.
13. van de Velde F, Lourenco ND, Pinheiro HM, Bakker M. Carrageenan: A food-grade and biocompatible support for immobilisation techniques. Adv Synth Catal 2002;344:815-835.
14. Bonferoni MC, Chetoni P, Giunchedi P, Rossi S, Ferrari F, Burgalassi S, Caramella C. Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies. Eur J Pharm Biopharm 2004;57:465-472.
15. Hosseinzadeh H. Controlled release of diclofenac sodium from pH-responsive carrageenan-g-poly(acrylic acid) superabsorbent hydrogel. J Chem Sci 2010;122:651-659.
16. Shidhaye SS, Thakkar PV, Dand NM, Kadam VJ. Buccal Drug Delivery of Pravastatin Sodium. AAPS Pharmscitech 2010;11:416-424.
17. Grenha A, Gomes ME, Rodrigues M, Santo VE, Mano JF, Neves NM, Reis RL. Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A 2010; 92:1265-1272.
18. Bani-Jaber A, Al-Aani L, Alkhatib H, Al-Khalidi B. Prolonged Intragastric Drug Delivery Mediated by Eudragit E-Carrageenan Polyelectrolyte Matrix Tablets. AAPS PharmSciTech 2011;1-8.
19. Santo VE, Frias AM, Carida M, Cancedda R, Gomes ME, Mano JF, Reis RL. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009;10:1392-1401.
20. Desai PD, Dave AM, Devi S. Entrapment of lipase into j-carrageenan beads and its use in hydrolysis of olive oil in biphasic system. J Mol Catal B: Enzym 2004;31:143-150.
21. Pereira RC, Scaranari M, Castagnola P, Grandizio M, Azevedo HS, Reis RL, Cancedda R, Gentili C. Novel injectable gel (system) as a vehicle for human articular chondrocytes in cartilage tissue regeneration. J Tissue Eng Regen Med 2009;3:97-106.
22. Popa EG, Gomes ME, Reis RL. Cell delivery systems using alginate- carrageenan hydrogel beads and fibers for regenerative medicine applications. Biomacromolecules 2011;12:3952-3961.
23. Popa E, Reis R, Gomes M. Chondrogenic phenotype of different cells encapsulated in j-carrageenan hydrogels for cartilage regeneration strategies. Biotechnol Appl Biochem 2012;59:132-141.
24. Popa EG, Caridade SG, Mano JF, Reis RL, Gomes ME. Chondrogenic potential of injectable j-carrageenan hydrogel with encapsulated adipose stem cells for cartilage tissue-engineering applications. J Tissue Eng Regen Med 2013. doi: 10.1002/ term.1683. [Epub ahead of print].
25. Silvia MM, Akhilesh KG, Rui LR, Alexandra PM, Manuela EG, Ali K. Photocrosslinkable j-carrageenan hydrogels for tissue engineering applications. Adv Health Mater 2013;2:895-907.
26. Selmi TAS, Verdonk P, Chambat P, Dubrana F, Potel JF, Barnouin L, Neyret P. Autologous chondrocyte implantation in a novel alginate- agarose hydrogel: Outcome at two years. J Bone Joint Surg- Series B 2008;90:597-604.
27. Lima EG, Bian L, Ng KW, Mauck RL, Byers BA, Tuan RS, Ateshian GA, Hung CT. The beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-b3. Osteoarthritis Cartilage 2007;15:1025-1033.
28. Mauck RL, Yuan X, Tuan RS. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage 2006;14:179-189.
29. Gomes ME, Reis RL, Cunha AM, Blitterswijk CA, de Bruijn JD. Cytocompatibility and response of osteoblastic-like cells to starchbased polymers: effect of several additives and processing conditions. Biomaterials 2001;22:1911-1917.
30. Marques AP, Reis RL, Hunt JA. Evaluation of the potential of starch-based biodegradable polymers in the activation of human inflammatory cells. J Mater Sci: Mater Med 2003;14:167-173.
31. Santos TC, Marques AP, Silva SS, Oliveira JM, Mano JF, Castro AG, Reis RL. In vitro evaluation of the behaviour of human polymorphonuclear neutrophils in direct contact with chitosan-based membranes. J Biotechnol 2007;132:218-226.
32. Opoku G, Qiu XD, Doctor V. Effect of oversulfation on the chemical and biological properties of kappa carrageenan. Carbohydr Polym 2006;65:134-138.
33. Silva FRF, Dore CMPG, Marques CT, Nascimento MS, Benevides NMB, Rocha HAO, Chavante SF, Leite EL. Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans. Carbohydr Polym 2010;79, 26-33.
34. Bhattacharyya S, Liu HY, Zhang ZQ, Jam M, Dudeja PK, Michel G, Linhardt RJ, Tobacman JK. Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds. J Nutr Biochem 2010;21:906-913.
35. Zhou G, Sun Y, Xin H, Zhang Y, Li Z, Xu Z. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol Res 2004;50:47-53.
36. Cheng A-C, Chen Y-Y, Chen J-C. Dietary administration of sodium alginate and j-carrageenan enhances the innate immune response of brown-marbled grouper Epinephelus fuscoguttatus and its resistance against Vibrio alginolyticus. Vet Immunol Immunopathol 2008;121:206-215.
37. Yuan H, Song J, Li X, Li N, Dai J. Immunomodulation and antitumor activity of j-carrageenan oligosaccharides. Cancer Lett 2006; 243:228-234.
38. Ratheesh AHM. Anti-inflammatory activity of Ruta graveolens Linn on carrageenan induced paw edema in wistar male rats. Afr J Biotechnol 2007;6:1209-1211.
39. Esposito E, Iacono A, Raso GM, Pacilio M, Coppola A, Di Carlo R, Meli R. Raloxifene, a selective estrogen receptor modulator, reduces Carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 2005;146:3301-3308.
40. Cicala C, Morello S, Alfieri A, Vellecco V, Marzocco S, Autore G. Haemostatic imbalance following carrageenan-induced rat paw oedema. Eur J Pharmacol 2007;577:156-161.
41. Rossi A, Di Paola R, Mazzon E, Genovese T, Caminiti R, Bramanti P, Pergola C, Koeberle A, Werz O, Sautebin L, Cuzzocrea S. Myrtucommulone from Myrtus communis Exhibits Potent Anti-Inflammatory Effectiveness in Vivo. J Pharmacol Exp Therap 2009;329: 76-86.
42. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008;20:86-100.
43. Stohs SJ. The Role of Free Radicals in Toxicity and Disease. J Basic Clin Physiol Pharmacol 1995;6:205-228.
44. Kozumbo WJ, Trush MA, Kensler TW. Are free radicals involved in tumor promotion?. Chemico-Biol Interact 1985;54:199-207.
45. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts. Science 1997;275:1649-1652.
46. Dröge W. Free Radicals in the Physiological Control of Cell Function. Physiol Rev 2002;82:47-95.
47. McPhail LC, Henson PM, Johnston RB. Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J Clin Investig 1981;67:710-716.
48. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Investig 1987;80:1550-1560.
49. Kindzelskii AL, Petty HR. Apparent role of traveling metabolic waves in oxidant release by living neutrophils. Proc Natl Acad Sci USA 2002;99:9207-9212.
50. Jiao G, Yu G, Zhang J, Ewart H. Chemical Structures and Bioactivities of Sulfated Polysaccharides from Marine Algae. Marine Drugs 2011;9:196-223.
51. Meyvis TKL, De Smedt SC, Demeester J, Hennink WE. Influence of the Degradation Mechanism of Hydrogels on Their Elastic and Swelling Properties during Degradation. Macromolecules 2000;33: 4717-4725.
52. Coutinho DF, Sant SV, Shin H, Oliveira JOT, Gomes ME, Neves NM, Khademhosseini A, Reis RL. Modified Gellan Gum hydrogels with tunable physical and mechanical properties. Biomaterials 2010;31:7494-7502.
53. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix Metalloproteinases: A Review. Crit Rev Oral Biol Med 1993;4:197-250.
54. Zwadlo G, Voegeíi R, Osthoff KS, Sorg C. A Monoclonal Antibody to a Novel Differentiation Antigen on Human Macrophages Associated with the Down-Regulatory Phase of the Inflammatory Process. Pathobiology 1987;55:295-304.
55. Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011;32: 6692-6709.
56. Tedgui A, Mallat Z. Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways. Physiol Rev 2006;86:515-581.